UTMB develops a universal vaccine platform that’s cheaper and shelf stable
Researchers at The University of Texas Medical Branch at Galveston have developed a less expensive way to produce vaccines that cuts the cost of vaccine production and storage by 80 percent without decreasing safety or effectiveness. The findings are currently available in EBioMedicine.
Vaccines are the most effective way to prevent and eradicate infectious diseases. Currently, many vaccines have to be manufactured in cell culture or eggs, which is expensive and carries the risk of contaminations. In addition, most vaccines must be kept refrigerated during the transportation from manufacturers to health care clinics. In tropical and subtropical regions, such cold storage requirements could contribute to more than 80 percent of the vaccine cost.
“The ability to eliminate cell culture or eggs and cold storage will change the process of vaccine development,” said UTMB’s Pei-Yong Shi, professor in the department of biochemistry and molecular biology. “Importantly, this vaccine technology could potentially serve as a universal platform for development of live-attenuated vaccines for many viral pathogens.”
To achieve these goals, the UTMB team engineered a live-attenuated Zika vaccine in the DNA form. Once the DNA is delivered into our body, it launches the vaccine in our cells, leading to antibody production and other protective immunity. With this production method, there is no need to manufacture the vaccine in cell culture or eggs at factories. Because DNA molecules are shelf stable, the vaccine will not expire at warm temperatures and could be stockpiled at room temperature for years.
Using UTMB’s Zika vaccine as a model, the research group showed that the DNA platform worked very efficiently in mice. After a single low dose, the DNA vaccine protected mice from Zika virus infection, mother-to-fetus transmission during pregnancy and male reproductive tract infection and damage.
“This is the first study to demonstrate that, after a single low dose, a DNA vaccine could induce saturated protective immunity,” Shi said. “We will continue testing this promising Zika vaccine platform and then apply the platform to other viruses.”
The Latest on: Vaccine production
via Google News
The Latest on: Vaccine production
- Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Key Players, Product and Production Information analysis and forecast to 2023 on December 9, 2018 at 8:43 am
Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Production, Supply, Sales, and Demand Market Research Report is a systematically conducted exhaustive study of the Global Porcine Repro... […]
- Global Equine Influenza Vaccine Market 2018-2023 Revenue (Value), Production, Price Trend Type and Application on December 6, 2018 at 7:17 pm
Equine Influenza Vaccine Market greatest size in Global, Equine Influenza Vaccine Market is required to High its market estimate in Upcoming Years, Equine Influenza Vaccine Market Increasing Growth in ... […]
- Canadian scientists developing new HIV vaccine on December 3, 2018 at 8:57 am
A group of Canadian researchers with expertise in vaccine development, HIV immunology and vaccine production have joined together to develop what will hopefully be the world’s first regulatory approve... […]
- Global Lyme Disease Vaccine Market Production: Regional Analysis for United States, Europe, China, Japan and Others on December 2, 2018 at 4:00 pm
(EMAILWIRE.COM, December 03, 2018 ) Global Lyme Disease Vaccine Market analyzes on key Lyme Disease Vaccine manufacturers and study the capacity, production, value, market share and development plans ... […]
- China proposes new laws on vaccine management on November 11, 2018 at 5:02 pm
... management which seek to tighten the supervision and management of how vaccines enter the country’s market and will also require stricter management of their production, research and distribution. ... […]
- China fines company for illegal human rabies vaccine production on October 16, 2018 at 5:57 am
BEIJING, Oct. 16 (Xinhua) -- Chinese authorities on Tuesday handed out penalties totaling more than 9.1 billion yuan (1.32 billion U.S. dollars) to a company for the illegal production of a human rabi... […]
- Team develops a universal vaccine platform that's cheaper and shelf stable on October 5, 2018 at 5:59 pm
... of Texas Medical Branch at Galveston have developed less expensive way to produce vaccines that cuts the costs of vaccine production and storage by up to 80 percent without decreasing safety or ef... […]
- Vietnam ready to produce influenza vaccines on September 24, 2018 at 7:13 pm
“This is the result of a nine-year international partnership to improve Việt Nam ’s vaccine production capacity and pandemic preparedness,” he said. Overall results showed that both vaccines are accep... […]
via Bing News